Renaissance of cancer therapeutic antibodies.

@article{Glennie2003RenaissanceOC,
  title={Renaissance of cancer therapeutic antibodies.},
  author={Martin J. Glennie and Jan G. J. van de Winkel},
  journal={Drug discovery today},
  year={2003},
  volume={8 11},
  pages={503-10}
}
In the past five years therapeutic monoclonal antibodies have established themselves as perhaps the most important and rapidly expanding class of therapeutic drugs. More than 25% of pharmacological agents that are currently under development are based on antibodies and the total income generated from them in 2002 exceeded $3 billion, and is predicted to rise to $10-20 billion by 2010. Many experts feel that antibodies directed at cancer targets are likely to dominate the market for the… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
54 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 54 extracted citations

Similar Papers

Loading similar papers…